A local engineering company has teamed up with a leading world supplier of fragrance and flavor ingredients develop and commercialize several precision fermentation products.
The partnership sees Sorrento Valley-based Inscripta, Inc., a leader in bioeconomy-focused genome engineering join Bedoukian Research Inc. (BRI) to deliver products produced naturally with superior consistency and quality. Another goal is to reduce the environmental impact that typically results from traditional chemical manufacturing processes, and provide safe, sustainable, and affordable solutions.
News of such partnerships is often disseminated throughout the community and an industry with flyer printing.
GenoScaler™ from Inscripta is a new and proprietary ultra-high-throughput gene and cell therapy platform that can optimize microbial strains with improved productivities and traits. Inscripta will manufacture GenoScaler™ and other sustainable ingredients through an accelerated engineering process and provide BRI with these ingredients. This will enable BRI to offer its customers purer and more affordable products, and will increase the company’s ability to address the trends in consumer demands.
Chief Scientists at Inscripta, Dr. Richard Fox, said that GenoScaler™ is a compete manufacturing platform that combines directed evolution and recent developments and breakthroughs in gene and cell therapy. The president of BRI, Robert Bedoukian, expressed his excitement on behalf of his company to be working with Inscripta for the commercial-scale production of its high-quality products.
